A Decade of Experience Using mTor Inhibitors in Liver Transplantation by Jeffrey Campsen, Michael A. Zimmerman, Susan Mandell, Maria Kaplan, Igal Kam

“…We compared patients who received SRL or CNI in the first year after liver transplant. Our database included 688 patients who received a liver transplant. …”
Get full text

Ehrlichiosis in a Recent Liver Transplant Recipient Leading to Multiorgan Failure by Fawwaz Almajali, Catherine Oleary, Taylor Hallcox, Justin Lok, Daniela Hermelin, Alexis Guenette, Mustafa Nazzal

“…While Ehrlichia often presents as a mild form of the disease in immunocompetent patients, immunosuppressed patients are at increased risk for a more virulent and potentially fatal infection. Our liver transplant patient presented with fever, persistent headaches, and negative Ehrlichia antibodies. …”
Get full text

Comment on Portal Hemodynamics in Liver Transplantation: Do not Shunt The Large-For-Flow! by Xavier Muller, MD, PhD, Guillaume Rossignol, MD, Kayvan Mohkam, MD, PhD, Jean-Yves Mabrut, MD, PhD

Get full text

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma by Parissa Tabrizian, Rebecca Marino, Sherrie Bhoori, Marcus Zeitlhoefler, Neil Mehta, Vanessa Banz, Salvatore Gruttadauria, Massimo Iavarone, Chiara Mazzarelli, Nicolò Simonotti, Francis Yao, Vincenzo Mazzaferro, Josep M. Llovet

Subjects: Get full text

Aggressive Recurrence of Primary Hepatic Epithelioid Haemangioendothelioma after Liver Transplantation by Qusay A. Abdoh, Asma M. Alnajjar, Faisal A. Abaalkhail, Mohammed Al Sebayel, Hussa F. Al-Hussaini, Waleed K. Al-Hamoudi, Hazem Helmy, Mohamad Almansour, Hussien A. Elsiesy

“…HEHE can have rapid and aggressive recurrence after liver transplantation.…”
Get full text

Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication by Anna Lang, Cameron Goff, Ashley Montgomery, Jake Lynn, Spoorthi Kamepalli, John Goss, Abbas Rana

“…The impact of indication for pediatric liver transplantation on waitlist and post-transplant mortality outcomes is well known, but the impact on intent-to-treat outcomes has not been investigated. …”
Get full text

Recipient Age Predicts 20-Year Survival in Pediatric Liver Transplant by Stephanie Keeling, Malcolm F. McDonald, Adrish Anand, Jordan Dunson, Elizabeth Williams, Theodore Zhang, Brian Hickner, Nhu Thao Nguyen Galván, Christine O’ Mahony, John A Goss, Abbas Rana

“…Introduction. Pediatric liver transplant recipients have demonstrated excellent long-term survival. …”
Get full text

The Role of Endoscopy in the Treatment of Biliary Complications after Orthotopic Liver Transplantation by Alexey V. Kurenkov, Yury S. Teterin, Oleg D. Olisov, Petr A. Yartsev, Murad S. Novruzbekov, Kubay M. Magomedov

Subjects: “…orthotopic liver transplantation…”
Get full text

Donor-derived Cryptococcus gattii complex infection after liver transplantation by Bruno Hassunuma Carneiro, Giovanni Luis Breda, Regielly Caroline Raimundo Cognialli, Germana Davila dos Santos, Vania Aparecida Vicente, Eduardo Gnoatto Perondi, João Cesar Beenke França, Flávio Queiroz-Telles

“…Donor-derived Cryptococcus spp. infection typically manifests within the first month post-procedure and has historically been caused by C. neoformans complex, predominantly in kidney recipients, but also after liver transplantation. We report the first documented case of donor-derived, early-onset C. gattii complex meningoencephalitis following liver transplantation in a 54-year-old woman, successfully treated with amphotericin B and fluconazole, and review the relevant literature.…”
Get full text

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis by O. D. Olisov, M. S. Novruzbekov, I. E. Galankina, L. N. Zimina, V. A. Gulyaev, L. V. Donova, M. Sh. Khubutiya

Subjects: Get full text

Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients by Edward Kim, Alina Adeel, Adel Bozorgzadeh, Shinya Amano, Curtis T. Barry, Jennifer S. Daly, Deepika Devuni, Zendee Elaba, Laura Houk, Paulo N. Martins, Babak Movahedi, Muthalagu Ramanathan, Nicole M. Theodoropoulos

“…Acute graft-versus-host disease (aGvHD) is a rare complication of liver transplantation associated with high morbidity and mortality. …”
Get full text

Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center by Ye. N. Bessonova, O. A. Stroganova, Yu. A. Glazyrina, I. A. Kornilova

“…To carry out integrated analysis of the liver cirrhosis group of patients and indications for transplantation with evaluation of leading causes and factors affecting shifting liver transplantation in the Waiting list.Material and methods. …”
Get full text

Uncommon Occurrence of an Air Embolism during the Preanhepatic Phase of an Orthotopic Liver Transplant by Klint J. Smart, Saman Yaghoubian

“…Vascular air embolism (VAE) during liver transplantation usually occurs during the dissection phase of the procedure or during liver reperfusion. …”
Get full text

Right Gastroepiploic Artery as an Alternative for Arterial Reconstruction in Living Donor Liver Transplantation by Klaus Steinbrück, Reinaldo Fernandes, Marcelo Enne, Rafael Vasconcelos, Giuliano Bento, Gustavo Stoduto, Thomas Auel, Lúcio Filgueiras Pacheco-Moreira

“…An adequate blood flow is directly related to graft survival in living donor liver transplantation. However, in some cases, unfavorable conditions prevent the use of the hepatic artery for arterial reconstruction. …”
Get full text

Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience by Hala Hassanain, MD, Ashton A. Connor, MD, PhD, Elizabeth W. Brombosz, PhD, Khush Patel, MD, MS, Ahmed Elaileh, MD, Tamneet Basra, MD, Sudha Kodali, MD, MSPH, David W. Victor, III, MD, Caroline J. Simon, MD, Yee Lee Cheah, MD, Mark J. Hobeika, MD, Constance M. Mobley, MD, PhD, Ashish Saharia, MD, Sadhna Dhingra, MD, Mary Schwartz, MD, Anaum Maqsood, MD, Kirk Heyne, MD, Ahmed O. Kaseb, MD, Jean-Nicolas Vauthey, MD, A. Osama Gaber, MD, Maen Abdelrahim, MD, PhD, R. Mark Ghobrial, MD, PhD

“…Hepatocellular carcinoma (HCC) has a rising incidence and mortality in North America. Liver transplantation (LT) with adjunctive therapies offers excellent outcomes. …”
Get full text

Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation by Harsh D. Patel, Moises I. Nevah Rubin

“…It is a condition with a low incidence of 3.5–4.3% in liver transplant (LT) recipients. This case involves a 63-year-old male with history of LT for chronic HCV induced cirrhosis who presented with abdominal distension related to worsening ascites. …”
Get full text

Association of a Liver Allocation Policy Change With Domestic Travel for Liver Transplantation by Katie Ross-Driscoll, PhD, MPH, Chandrashekhar Kubal, MD, PhD, Arrey-Takor Ayuk-Arrey, MPH, Jonathan Fridell, MD, David Axelrod, MD, MBA

“…Our objective was to describe patterns of travel for domestic liver transplant pre- and post–acuity circle (AC) implementation. …”
Get full text

Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases by Ehab E. Abdel-Khalek, Alrefaey K. Alrefaey, Amr M. Yassen, Ahmed Monier, Hesham M. Elgouhari, Mohamed Samy Habl, Gehad Tawfik, Thuraya Elzayat, Reham Adly Zayed, Mohamed Abdel-Wahab

“…The possible risk factors for chronic kidney disease in transplant recipients have not been thoroughly investigated after living-donor liver transplantation. Material and Methods. A retrospective cohort study of consecutive adults who underwent living-donor liver transplantation between May 2004 and October 2016, in a single center, was conducted. …”
Get full text

Hepatitis B Associated Monoclonal Gammopathy That Resolved after Successful Liver Transplant by P. Sreenivasan, S. Nair

“…Here, we report a case of IgA-kappa light chain gammopathy secondary to Hepatitis B infection, which resolved after liver transplantation. To our knowledge, this is the first reported case of M protein spike seen in the context of Hepatitis B infection only.…”
Get full text

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma by Kirti Shetty, Chiranjeev Dash, Jacqueline Laurin

“…The efficacy of liver transplantation (LT) for hepatocellular (HCC) is limited by tumor recurrence rates of 10–15%. …”
Get full text